US 8,602,273

Application 13/038,211 · Granted Dec 10, 2013

Safety can

Estimated expiration

August 20, 2031

4y 272d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Mar 1, 2011
+ 20 years
Mar 1, 2031
PTA +172d
Aug 20, 2031
No TD
—
Final
Aug 20, 2031

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
March 1, 2011
Earliest effective filing
March 1, 2011
Issue date
December 10, 2013
PTA
+172 days
Base expiry (before PTA)
March 1, 2031

March 1, 2011 + 20 years = March 1, 2031 + 172 PTA days = August 20, 2031

  • PRO61/309,345 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 13/038,211 · US 8,602,273

PatentReply compiles the prosecution history behind US 8,602,273: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US8602273

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.